4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000101
EVP, Chf Clinical Develop Ofcr sold 6,179 shares at $83.45 ($515,630)
- EVP, Chf Clinical Develop Ofcr acquired 11,991 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneider Eugene EVP, Chf Clinical Develop Ofcr | 2026-01-29 | Grant or award | +11,991 | 75,881 | D: show line 1 in the form | ||
| Schneider Eugene EVP, Chf Clinical Develop Ofcr | 2026-01-30 | Sale | −6,179 | $83.45 | $515,630 | 69,702 | D: show line 2 in the form |
| Open-market sales · 6,179 sh · avg $83.45 · $515,630 | |||||||
Loading xslF345X05/edgardoc.xml…